The Challenge of CMC Regulatory Compliance for Biopharmaceuticals - Image 1

£160.28

Springer The Challenge of CMC Regulatory Compliance for Biopharmaceuticals

Name: The Challenge of CMC Regulatory Compliance for Biopharmaceuticals
Brand: Springer
Price: 160.2 GBP
Availability: InStock

Law

Price History & Forecast

Last 29 days • 29 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 29 days • 1 price levels

Days at Price

Price Analysis

Most common price: £160 (29 days, 100.0%)

Price range: £160 - £160

Price levels: 1 different prices over 29 days

Description

"The greater our knowledge increases, the more our ignorance unfolds. " U. S. President John F. Kennedy, speech, Rice University, September 12, 1962 My primary purpose for writing this book was much more than to provide another information source on Chemistry, Manufacturing & Controls (CMC) that would rapidly become out of date. My primary purpose was to provide insight and practical suggestions into a common sense business approach to manage the CMC regulatory compliance requirements for biopharmaceuticals. Such a common sense business approach would need (1) to be applicable for all types of biopharmaceutical products both present and future, (2) to address the needs of a biopharmaceutical manufacturer from the beginning to the end of the clinical development stages and including post market approval, and (3) to be adaptable to the constantly changing CMC regulatory compliance requirements and guidance. Trying to accomplish this task was a humbling experience for this author! In Chapter 1, the CMC regulatory process is explained, the breadth of products included under the umbrella ofbiopharmaceuticals are identified, and the track record for the pharmaceutical and biopharmaceutical industry in meeting CMC regulatory compliance is discussed. In Chapter 2, while there are many CMC commonalities between biopharmaceuticals and chemically-synthesized pharmaceuticals, the significant differences in the way the regulatory agencies handle them are examined and the reasons for why such differences are necessary is discussed. Also, the importance of CMC FDA is stressed.

Product Specifications

Brand: Springer
Format: hardcover
ASIN: 0306480409
Category: Books > Subjects > Business, Finance & Law > Law
Domain: Amazon UK
Release Date: 31 December 2003
Listed Since: 07 February 2007

Barcode

No barcode data available

Springer The Challenge of CMC Regulatory Compliance for Biopharmaceuticals

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

The Challenge of CMC Regulatory Compliance for Biopharmaceuticals

The Challenge of CMC Regulatory Compliance for Biopharmaceuticals

The Challenge of CMC Regulatory Compliance for Biopharmaceuticals

The Challenge of CMC Regulatory Compliance for Biopharmaceuticals

Biopharmaceuticals: Challenges and Opportunities

Statistical Applications for Chemistry, Manufacturing and Controls (CMC) in the Pharmaceutical Industry (Statistics for Biology and Health)

Statistical Applications for Chemistry, Manufacturing and Controls (CMC) in the Pharmaceutical Industry (Statistics for Biology and Health)

Supply Chain Management in the Drug Industry: Delivering Patient Value for Pharmaceuticals and Biologics

Quality Control Training Manual: Comprehensive Training Guide for API, Finished Pharmaceutical and Biotechnologies Laboratories

Wiley - Biological Drug Products: Development and Strategies

Biopharmaceutics Applications in Drug Development

FDA Regulatory Affairs: A Guide for Prescription Drugs, Medical Devices, and Biologics

Development of Biopharmaceutical Drug-Device Products: 35 (AAPS Advances in the Pharmaceutical Sciences Series, 35)

Regulated Bioanalysis: Fundamentals and Practice: 26 (AAPS Advances in the Pharmaceutical Sciences Series, 26)

Chembiomolecular Science: At the Frontier of Chemistry and Biology

Challenges in Protein Product Development: 38 (AAPS Advances in the Pharmaceutical Sciences Series, 38)

Development of Biopharmaceutical Drug-Device Products: 35 (AAPS Advances in the Pharmaceutical Sciences Series, 35)

Biosimilars Development Strategies: Fast to Market Approaches

Biopharmaceutical Supply Chains: Distribution, Regulatory, Systems and Structural Changes Ahead

Nonclinical Development of Novel Biologics, Biosimilars and Specialty Biologics

Biosimilar and Interchangeable Biologics: From Cell Line to Commercial Launch, Two Volume Set

Chemokines: Chemokines and Their Receptors in Drug Discovery: 14 (Topics in Medicinal Chemistry, 14)

Chemokines: Chemokines and Their Receptors in Drug Discovery: 14 (Topics in Medicinal Chemistry, 14)

Statistics for Biotechnology Process Development